Supplementary Figure 1 from Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers

Laleh Amiri-Kordestani,Victoria Luchenko,Cody J. Peer,Kambiz Ghafourian,James Reynolds,Deb Draper,Robin Frye,Sue Woo,David Venzon,John Wright,Monica Skarulis,William D. Figg,Tito Fojo,Susan E. Bates,Richard L. Piekarz

crossref（2023）

Cited 0|Views18

No score

Abstract

Supplementary Figure 1 - PDF file 176K, Supplementary Figure 1: Comparison of dose-normalized CMAX (A) and AUCLAST (B) for the present phase I trial versus data obtained on the phase II NCI1312 trial

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined